Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 225

Results For "EMA"

2609 News Found

Pfizer to acquire Arena Pharmaceuticals for US $ 6.7 bn
News | December 14, 2021

Pfizer to acquire Arena Pharmaceuticals for US $ 6.7 bn

The proposed acquisition offers a potentially new, differentiated best-in-class approach to address the unmet need for a broader number of patients with immuno-inflammatory diseases


Atik Cameras launches the TE-77 advanced scientific solution
Medical Device | December 14, 2021

Atik Cameras launches the TE-77 advanced scientific solution

Atik Cameras invests in new CCD sensor technology to create an advanced scientific and industrial imaging solution, using the Teledyne e2v CCD77-00 sensor


Lupin’s Goa plant receives EIR from US FDA
News | December 14, 2021

Lupin’s Goa plant receives EIR from US FDA

FDA changes inspection classification of the facility to Voluntary Action Indicated


ICMR Dibrugarh designs kit to detect Omicron variant in two hours
News | December 13, 2021

ICMR Dibrugarh designs kit to detect Omicron variant in two hours

GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model


Kaka-Ba hospital surgeons perform surgery to correct spine disorder
Hospitals | December 13, 2021

Kaka-Ba hospital surgeons perform surgery to correct spine disorder

Scoliosis is a disorder of the spine, and its surgeries are generally done only in large hospitals in big cities.


Moderna announces positive interim Phase 1 data for mRNA flu vaccine
Biotech | December 13, 2021

Moderna announces positive interim Phase 1 data for mRNA flu vaccine

Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed


Venky’s sets up plant to manufacture veterinary medicinal products
News | December 13, 2021

Venky’s sets up plant to manufacture veterinary medicinal products

The total cost of the project is estimated at Rs 30 crore


Nova Nordisk to invest 17 bn Danish kroner to expand capacity in Denmark
Biotech | December 13, 2021

Nova Nordisk to invest 17 bn Danish kroner to expand capacity in Denmark

The investment will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to assembly and packaging, with the vast majority being invested in API capacity


SPARC to present clinical data on vodobatinib
Biotech | December 11, 2021

SPARC to present clinical data on vodobatinib

Results from the ongoing vodobatinib clinical study are being presented for the second consecutive year at the ASH annual meeting, underlining the promising potential of the drug for the treatment of heavily pre-treated CML


Zydus receives  USFDA  approval for Phase2(b)/3 trial of Saroglitazar
Biotech | December 10, 2021

Zydus receives USFDA approval for Phase2(b)/3 trial of Saroglitazar

Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)